CellKey Partnership Poised to Reshape Bioanalytical Research

(Source: Cellkey)

On August 29th, Cellkey marked a momentous occasion with the official Memorandum of Understanding (MOU) ceremony alongside Emerald Cloud Lab (ECL) – a true trailblazer in cloud-based laboratory facilities. The event brought together Je Min Yoo from CellKey, Jennifer Henry-Smith, Louis Sintasath, Jake Hostetler from ECL, and Kwame Ulmer, CellKey’s mentor, through BioHealth Innovation, Inc.’s US market entry program.

This dynamic collaboration propels us into an exciting journey to revolutionize protein and glycoprotein analysis, a critical domain for diagnosing and treating diseases, including cancer.

The synergy of CellKey and ECL, fueled by ECL's advanced lab tech, opens new horizons. Our SpAC9 Data Foundry, the proprietary glycoprotein analysis platform, now empowers global researchers. This shift enables cutting-edge remote glycoprotein and protein analysis, breaking barriers and fostering collaborative innovation.

Beyond tech, it is also about researcher support. Our partnership with ECL exemplifies our dedication to global access to advanced facilities, propelling us toward innovation without borders.

I’m excited to be partnering with an outstanding group of innovators who are taking steps to create medtech and research support that will make great strides in the fight against cancer and treating diseases. - Kwame Ulmer